AFP and hepatocellular carcinoma: Xu et al. constructed a diagnostic prediction model using a cfDNA methylation marker panel that predicted HCC survival and could effectively discriminate patients with HCC from individuals with HBV/HCV infection, fatty liver disease as well as healthy controls superior to AFP (Xu et al. 2017).